INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 440,668 Value ($000) $58,133 Avg Close — Range —
Q4 2024
Shares 1,079,757 Value ($000) $90,181 Avg Close — Range —
Q3 2024
Shares 1,160,973 Value ($000) $84,948 Avg Close — Range —
Q2 2024
Shares 499,015 Value ($000) $34,178 Avg Close — Range —
Q4 2023
Shares 24,249 Value ($000) $1,737 Avg Close — Range —
Q3 2023
Shares 42,948 Value ($000) $2,237 Avg Close — Range —
Q2 2023
Shares 108,448 Value ($000) $6,867 Avg Close — Range —
Q1 2022
Shares 2,519,764 Value ($000) $154,185 Avg Close — Range —
Q4 2021
Shares 2,388,294 Value ($000) $125,003 Avg Close — Range —
Q3 2021
Shares 2,295,634 Value ($000) $85,582 Avg Close — Range —
Q2 2021
Shares 2,771,304 Value ($000) $113,125 Avg Close — Range —
Q1 2021
Shares 2,834,460 Value ($000) $96,174 Avg Close — Range —
Q4 2020
Shares 3,015,732 Value ($000) $95,900 Avg Close — Range —
Q3 2020
Shares 3,012,377 Value ($000) $77,298 Avg Close — Range —
Q2 2020
Shares 1,317,930 Value ($000) $33,831 Avg Close — Range —
Q1 2020
Shares 684,778 Value ($000) $10,526 Avg Close — Range —
Q2 2016
Shares 9,820 Value ($000) $381 Avg Close — Range —
Q4 2015
Shares 23,148 Value ($000) $1,245 Avg Close — Range —
Q3 2015
Shares 18,738 Value ($000) $750 Avg Close — Range —